Studie untersucht Übernahmen von globalen Pharmafirmen im Antidiabetika-Markt zwischen 1997 und 2017 – Marktführer tätigen viel seltener Übernahmen als kleine, forschungsorientierte Firmen – Ergebnisse deuten nicht auf Marktverdrängungsabsichten (Killer-Akquisitionen) hin – Wettbewerbsbehörden sollten Fokus mehr auf Innovationsmärkte richten Die Pharmaindustrie, eine der forschungsintensivsten Branchen ...
24. Juni 2024 – Um die Klimaziele zu erreichen, müssen die Treibausgasemissionen im Straßengüterverkehr deutlich reduziert werden. Hierfür werden verschiedene Möglichkeiten diskutiert, vor allem der verstärkte Einsatz von batterieelektrischen Fahrzeugen oder solchen mit Wasserstoff-Brennstoffzellen. Eine Studie von Forschern des DIW Berlin und des Instituts für Energie- und Umweltforschung...
The emerging net zero paradigm requires economies to go green; and Europe’s ambition is to lead the way. This requires directing technological change toward cleaner growth, which intersects with green industrial policies in the form of green innovation subsidies. Leveraging a quasi-exhaustive novel dataset on German R&D subsidies, we provide rigorous evidence on whether green R&D subsidies...
Climate policy will inevitably lead to the stranding of fossil energy assets such as production and transport assets for coal, oil, and natural gas. Resource-rich developing countries are particularly affected, as they have a higher risk of asset stranding due to strong fossil dependencies and wider societal consequences beyond revenue disruption. However, there is only little academic and political ...
We analyze if technological progress and the change in the occupational structure have improved women’s position in the labour market. We show that women increasingly work in non-routine manual and in interactive occupations. However, the observed narrowing of the gender wage gap is entirely driven by declining gender wag gaps within, rather than between, occupations. A decomposition exercise reveals ...
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms’ technology dimension using patent information, next to their position in product markets. This allows us to identify the identity of targets and acquirers ...